Effect of the leukotriene B4 receptor antagonist, SC-41930, on experimental allergic encephalomyelitis (EAE) in the guinea pig
- 1 September 1991
- journal article
- non rheumatic-inflammatory-diseases
- Published by Springer Nature in Inflammation Research
- Vol. 34 (1-2) , 172-174
- https://doi.org/10.1007/bf01993269
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Suppression of experimental autoimmune encephalomyelitis by sulfasalazineActa Neurologica Scandinavica, 1990
- SC-41930Drugs of the Future, 1990
- An investigation into the possible involvement of platelet activating factor in experimental allergic encephalomyelitis in ratsInflammation Research, 1989
- Pharmacological comparison of active and passive experimental allergic encephalomyelitis in the ratInflammation Research, 1989
- Suppression of experimental autoimmune encephalomyelitis by dual cyclo-oxygenase and 5-lipoxygenase inhibitionActa Neurologica Scandinavica, 1989
- Inhibition of Experimental Allergic Encephalomyelitis by a New Anti‐Inflammatory Compound–SK&F 86002Annals of the New York Academy of Sciences, 1988
- Diapedesis and the permeability of venous microvessels to protein macromolecules: The impact of leukotriene B4 (LTB4)Microvascular Research, 1988
- Hyperacute, neutrophilic, and localized forms of experimental allergic encephalomyelitis: A reviewActa Neuropathologica, 1974